Dirk Pleimes
Company: PentixaPharm GmbH
Job title: Chief Medical & Scientific Officer
Seminars:
Identifying Patient Responders & Non-responders Through CXCR4 Targeted Theranostic Approaches for Central Nervous System Lymphoma (CNSL) 12:15 pm
Uncovering the dose-finding clinical phase I/II study Predicting treatment responses Sharing clinical designRead more
day: C&S Track AM